# pathway_0153

[All questions](../README.md) · [Summary](../SUMMARY.md) · [Method](../METHOD.md) · [Exact reviewer input](../inputs/pathway_0153.txt)

**Task:** `pathway`  
**Expected answer:** **A** — Cell wall biogenesis

| Reviewer | Expected-answer support | Reasoning versus lookup |
|---|---|---|
| GPT-6 Luna | supported | reasoning-supported |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported |

The reviewers assess the question and its expected answer. Their agreement is not expert confirmation. An unusable review is an output failure, not a finding that the question is wrong.

## Complete original question

```text
[Protein Sequence]
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENIRQDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMKLPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFFKPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGACDAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFVTERGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK

[Multiple Choices]
A. Cell wall biogenesis
B. Bacterial outer membrane biogenesis
C. LPS O-antigen biosynthesis. .
D. chorismate biosynthesis
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Reviewer assessments

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt pathway annotation assigns this protein to cell wall biogenesis and peptidoglycan biosynthesis. That annotation is computational (HAMAP), while the cited studies characterize the protein as a D-Ala-D-Ser ligase, a function consistent with peptidoglycan precursor synthesis.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is consistent with the bacterial D-Ala-D-Ala ligase family of ATP-dependent ligases. Transferable family knowledge links this enzyme family—and its D-Ala-D-Ser resistance variants—to synthesis of the peptide portion of peptidoglycan precursors. That meaningfully favors cell wall biogenesis (A) over outer-membrane, LPS O-antigen, or chorismate biosynthesis.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Recognizing the ligase family and its role in peptidoglycan synthesis provides a credible distinction among the offered pathways without needing this exact protein's database record. The sequence alone may not establish every detail of its substrate specificity, but that precision is not needed to distinguish these choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The options name distinct pathways, and the peptidoglycan-related role supports A rather than the listed alternatives.


### Important caveats

- The explicit pathway annotation is computational; the supplied evidence cites experimental characterization of ligase activity, but the primary papers were not independently reviewed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with the bacterial D-Ala-D-Ala ligase family of ATP-dependent ligases. Transferable family knowledge links this enzyme family—and its D-Ala-D-Ser resistance variants—to synthesis of the peptide portion of peptidoglycan precursors. That meaningfully favors cell wall biogenesis (A) over outer-membrane, LPS O-antigen, or chorismate biosynthesis.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Recognizing the ligase family and its role in peptidoglycan synthesis provides a credible distinction among the offered pathways without needing this exact protein's database record. The sequence alone may not establish every detail of its substrate specificity, but that precision is not needed to distinguish these choices."
  },
  "case_id": "pathway_0153",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation assigns this protein to cell wall biogenesis and peptidoglycan biosynthesis. That annotation is computational (HAMAP), while the cited studies characterize the protein as a D-Ala-D-Ser ligase, a function consistent with peptidoglycan precursor synthesis."
  },
  "important_caveats": [
    "The explicit pathway annotation is computational; the supplied evidence cites experimental characterization of ligase activity, but the primary papers were not independently reviewed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The options name distinct pathways, and the peptidoglycan-related role supports A rather than the listed alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0153",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation assigns this protein to cell wall biogenesis and peptidoglycan biosynthesis. That annotation is computational (HAMAP), while the cited studies characterize the protein as a D-Ala-D-Ser ligase, a function consistent with peptidoglycan precursor synthesis.",
    "evidence_ids": ["C5", "H4", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is consistent with the bacterial D-Ala-D-Ala ligase family of ATP-dependent ligases. Transferable family knowledge links this enzyme family—and its D-Ala-D-Ser resistance variants—to synthesis of the peptide portion of peptidoglycan precursors. That meaningfully favors cell wall biogenesis (A) over outer-membrane, LPS O-antigen, or chorismate biosynthesis.",
    "missing_item_specific_fact": "",
    "reason": "Recognizing the ligase family and its role in peptidoglycan synthesis provides a credible distinction among the offered pathways without needing this exact protein's database record. The sequence alone may not establish every detail of its substrate specificity, but that precision is not needed to distinguish these choices."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The options name distinct pathways, and the peptidoglycan-related role supports A rather than the listed alternatives."
  },
  "important_caveats": [
    "The explicit pathway annotation is computational; the supplied evidence cites experimental characterization of ligase activity, but the primary papers were not independently reviewed here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (Q47720, VanC2 from Enterococcus casseliflavus) explicitly annotates the pathway as 'Cell wall biogenesis; peptidoglycan biosynthesis' (evidence codes ECO:0000255 via HAMAP-Rule MF_00047, and ECO:0000305 supported by experimental studies PubMed:9294159 and PubMed:9545431). VanC2 is a D-Ala-D-Ser ligase (EC 6.3.2.35) that modifies the peptidoglycan lipid II precursor (D-Ala-D-Ala → D-Ala-D-Ser) as part of vancomycin resistance. This is unambiguously part of peptidoglycan/cell wall biosynthesis. The sequence matches the source entry exactly.

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C6](#evidence-c6), [C7](#evidence-c7), [H4](#evidence-h4), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains conserved motifs of the D-Ala-D-Ala ligase (Ddl) / Van ligase superfamily, including the 'GCGILGNDSLTVGACDAISLVDGFFDFEEKYQL' region and the overall ~350-aa architecture typical of this enzyme family. Transferable knowledge from the extensively characterized Ddl/Van family (VanA, VanB, VanC, VanD, VanE, VanG, etc.) establishes that these ligases catalyze formation of the C-terminal dipeptide (D-Ala-D-Ala or modified D-Ala-D-Ser/D-Ala-D-Lac) of the peptidoglycan lipid precursor, placing them squarely in peptidoglycan (cell wall) biosynthesis. This family-level inference directly selects option A. The other options involve entirely different protein families: outer membrane biogenesis (Lpt, Bam, LPS transporters), LPS O-antigen biosynthesis (glycosyltransferases, ABC transporters, O-antigen polymerases), and chorismate biosynthesis (shikimate pathway enzymes AroA–AroH, chorismate synthase). None of these families share the Ddl/Van ligase fold or motifs present in the query sequence.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Recognition of the Ddl/Van ligase family from conserved sequence motifs (GCG, DFFDF, overall fold) and the well-established family-level functional assignment to peptidoglycan precursor synthesis constitutes legitimate transferable knowledge. This meaningfully distinguishes option A from B, C, and D, which involve mechanistically and structurally unrelated protein families. No target-specific database lookup is required.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options correspond to clearly distinct biosynthetic pathways involving unrelated protein families. The Ddl/Van ligase motif and peptidoglycan precursor modification role point unambiguously to cell wall biogenesis (A). Outer membrane biogenesis (B) is inapplicable to this Gram-positive organism and involves different machinery. LPS O-antigen (C) and chorismate (D) pathways involve entirely different enzyme classes.


### Important caveats

- The HAMAP-Rule annotation (ECO:0000255) is a computational family-transfer assignment; however, it is corroborated by two independent experimental studies (PubMed:9294159, PubMed:9545431) demonstrating VanC2's D-Ala-D-Ser ligase activity and its role in peptidoglycan precursor modification.
- The N-terminal ~100 residues of this 350-aa protein include a hydrophobic region that may represent a signal peptide or membrane-association segment, which is atypical for canonical Ddl but consistent with some Van ligases that are membrane-associated.
- The organism (Enterococcus casseliflavus, a Gram-positive bacterium) was not provided to the model, but this does not affect the pathway assignment since peptidoglycan biosynthesis is universal in bacteria.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains conserved motifs of the D-Ala-D-Ala ligase (Ddl) / Van ligase superfamily, including the 'GCGILGNDSLTVGACDAISLVDGFFDFEEKYQL' region and the overall ~350-aa architecture typical of this enzyme family. Transferable knowledge from the extensively characterized Ddl/Van family (VanA, VanB, VanC, VanD, VanE, VanG, etc.) establishes that these ligases catalyze formation of the C-terminal dipeptide (D-Ala-D-Ala or modified D-Ala-D-Ser/D-Ala-D-Lac) of the peptidoglycan lipid precursor, placing them squarely in peptidoglycan (cell wall) biosynthesis. This family-level inference directly selects option A. The other options involve entirely different protein families: outer membrane biogenesis (Lpt, Bam, LPS transporters), LPS O-antigen biosynthesis (glycosyltransferases, ABC transporters, O-antigen polymerases), and chorismate biosynthesis (shikimate pathway enzymes AroA–AroH, chorismate synthase). None of these families share the Ddl/Van ligase fold or motifs present in the query sequence.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Recognition of the Ddl/Van ligase family from conserved sequence motifs (GCG, DFFDF, overall fold) and the well-established family-level functional assignment to peptidoglycan precursor synthesis constitutes legitimate transferable knowledge. This meaningfully distinguishes option A from B, C, and D, which involve mechanistically and structurally unrelated protein families. No target-specific database lookup is required."
  },
  "case_id": "pathway_0153",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C6",
      "C7",
      "H4",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (Q47720, VanC2 from Enterococcus casseliflavus) explicitly annotates the pathway as 'Cell wall biogenesis; peptidoglycan biosynthesis' (evidence codes ECO:0000255 via HAMAP-Rule MF_00047, and ECO:0000305 supported by experimental studies PubMed:9294159 and PubMed:9545431). VanC2 is a D-Ala-D-Ser ligase (EC 6.3.2.35) that modifies the peptidoglycan lipid II precursor (D-Ala-D-Ala → D-Ala-D-Ser) as part of vancomycin resistance. This is unambiguously part of peptidoglycan/cell wall biosynthesis. The sequence matches the source entry exactly."
  },
  "important_caveats": [
    "The HAMAP-Rule annotation (ECO:0000255) is a computational family-transfer assignment; however, it is corroborated by two independent experimental studies (PubMed:9294159, PubMed:9545431) demonstrating VanC2's D-Ala-D-Ser ligase activity and its role in peptidoglycan precursor modification.",
    "The N-terminal ~100 residues of this 350-aa protein include a hydrophobic region that may represent a signal peptide or membrane-association segment, which is atypical for canonical Ddl but consistent with some Van ligases that are membrane-associated.",
    "The organism (Enterococcus casseliflavus, a Gram-positive bacterium) was not provided to the model, but this does not affect the pathway assignment since peptidoglycan biosynthesis is universal in bacteria."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options correspond to clearly distinct biosynthetic pathways involving unrelated protein families. The Ddl/Van ligase motif and peptidoglycan precursor modification role point unambiguously to cell wall biogenesis (A). Outer membrane biogenesis (B) is inapplicable to this Gram-positive organism and involves different machinery. LPS O-antigen (C) and chorismate (D) pathways involve entirely different enzyme classes."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0153",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (Q47720, VanC2 from Enterococcus casseliflavus) explicitly annotates the pathway as 'Cell wall biogenesis; peptidoglycan biosynthesis' (evidence codes ECO:0000255 via HAMAP-Rule MF_00047, and ECO:0000305 supported by experimental studies PubMed:9294159 and PubMed:9545431). VanC2 is a D-Ala-D-Ser ligase (EC 6.3.2.35) that modifies the peptidoglycan lipid II precursor (D-Ala-D-Ala → D-Ala-D-Ser) as part of vancomycin resistance. This is unambiguously part of peptidoglycan/cell wall biosynthesis. The sequence matches the source entry exactly.",
    "evidence_ids": ["C5", "C4", "C6", "C7", "H4", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains conserved motifs of the D-Ala-D-Ala ligase (Ddl) / Van ligase superfamily, including the 'GCGILGNDSLTVGACDAISLVDGFFDFEEKYQL' region and the overall ~350-aa architecture typical of this enzyme family. Transferable knowledge from the extensively characterized Ddl/Van family (VanA, VanB, VanC, VanD, VanE, VanG, etc.) establishes that these ligases catalyze formation of the C-terminal dipeptide (D-Ala-D-Ala or modified D-Ala-D-Ser/D-Ala-D-Lac) of the peptidoglycan lipid precursor, placing them squarely in peptidoglycan (cell wall) biosynthesis. This family-level inference directly selects option A. The other options involve entirely different protein families: outer membrane biogenesis (Lpt, Bam, LPS transporters), LPS O-antigen biosynthesis (glycosyltransferases, ABC transporters, O-antigen polymerases), and chorismate biosynthesis (shikimate pathway enzymes AroA–AroH, chorismate synthase). None of these families share the Ddl/Van ligase fold or motifs present in the query sequence.",
    "missing_item_specific_fact": "",
    "reason": "Recognition of the Ddl/Van ligase family from conserved sequence motifs (GCG, DFFDF, overall fold) and the well-established family-level functional assignment to peptidoglycan precursor synthesis constitutes legitimate transferable knowledge. This meaningfully distinguishes option A from B, C, and D, which involve mechanistically and structurally unrelated protein families. No target-specific database lookup is required."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options correspond to clearly distinct biosynthetic pathways involving unrelated protein families. The Ddl/Van ligase motif and peptidoglycan precursor modification role point unambiguously to cell wall biogenesis (A). Outer membrane biogenesis (B) is inapplicable to this Gram-positive organism and involves different machinery. LPS O-antigen (C) and chorismate (D) pathways involve entirely different enzyme classes."
  },
  "important_caveats": [
    "The HAMAP-Rule annotation (ECO:0000255) is a computational family-transfer assignment; however, it is corroborated by two independent experimental studies (PubMed:9294159, PubMed:9545431) demonstrating VanC2's D-Ala-D-Ser ligase activity and its role in peptidoglycan precursor modification.",
    "The N-terminal ~100 residues of this 350-aa protein include a hydrophobic region that may represent a signal peptide or membrane-association segment, which is atypical for canonical Ddl but consistent with some Van ligases that are membrane-associated.",
    "The organism (Enterococcus casseliflavus, a Gram-positive bacterium) was not provided to the model, but this does not affect the pathway assignment since peptidoglycan biosynthesis is universal in bacteria."
  ]
}
```

</details>

## Complete reviewer-only evidence and qualifications

These source excerpts were available to the reviewers. They were not included in the original benchmark-solving input.

**Source applicability:**

```json
{
  "actual_author_source_snapshot": "unknown",
  "benchmark_sequence_length": 350,
  "benchmark_sequence_sha256": "b4602f311134ca7446d9c233196a8829e27e15dc29e27680e1d34564cbfdd19c",
  "current_entry_audit": {
    "entryVersion": 149,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "1996-11-01",
    "sequenceVersion": 1
  },
  "current_record_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "current_sequence_comparison": "matched",
  "current_source_sequence_length": 350,
  "current_source_sequence_sha256": "b4602f311134ca7446d9c233196a8829e27e15dc29e27680e1d34564cbfdd19c",
  "current_status": "retrieved",
  "current_uniprot_release": "2026_03",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 147,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "historical_status": "retrieved",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "latest_at_cutoff_sequence_comparison": "matched",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed.",
  "requested_accession": "Q47720",
  "selected_historical_entry_version": 147,
  "selected_historical_record_sha256": "7cd95341b40880e3967efdffddc7f3a25c7982d99fb2b3f1cf21db004390d78a",
  "selected_historical_source_sequence_length": 350,
  "selected_historical_source_sequence_sha256": "b4602f311134ca7446d9c233196a8829e27e15dc29e27680e1d34564cbfdd19c",
  "selected_historical_version": {
    "accession": "Q47720",
    "database": "Swiss-Prot",
    "entryVersion": 147,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "VANC2_ENTCA",
    "sequenceVersion": 1
  }
}
```

**Qualifications:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C1",
  "excerpt": "\"Q47720\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/primaryAccession",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C2",
  "excerpt": "{\"entryVersion\":149,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"1996-11-01\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/entryAudit",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C3",
  "excerpt": "{\"commonName\":\"Enterococcus flavescens\",\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"AAA60990.1\",\"source\":\"EMBL\"}],\"lineage\":[\"Bacteria\",\"Bacillati\",\"Bacillota\",\"Bacilli\",\"Lactobacillales\",\"Enterococcaceae\",\"Enterococcus\"],\"scientificName\":\"Enterococcus casseliflavus\",\"taxonId\":37734}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/organism",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C4",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000255\",\"id\":\"MF_00047\",\"source\":\"HAMAP-Rule\"}],\"value\":\"D-alanine--D-serine ligase\"}},{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"VanC2 ligase\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"9294159\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"9545431\",\"source\":\"PubMed\"}],\"value\":\"6.3.2.35\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"9294159\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Vancomycin C-type resistance protein VanC2\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/proteinDescription",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000255\",\"id\":\"MF_00047\",\"source\":\"HAMAP-Rule\"}],\"value\":\"Cell wall biogenesis; peptidoglycan biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/comments/5",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C6",
  "excerpt": "{\"citation\":{\"authors\":[\"Park I.S.\",\"Lin C.H.\",\"Walsh C.T.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"9294159\"},{\"database\":\"DOI\",\"id\":\"10.1073/pnas.94.19.10040\"}],\"citationType\":\"journal article\",\"firstPage\":\"10040\",\"id\":\"9294159\",\"journal\":\"Proc. Natl. Acad. Sci. U.S.A.\",\"lastPage\":\"10044\",\"publicationDate\":\"1997\",\"title\":\"Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase.\",\"volume\":\"94\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceComments\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"9294159\",\"source\":\"PubMed\"}],\"type\":\"STRAIN\",\"value\":\"ATCC 25788\"}],\"referenceNumber\":4,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"ACTIVITY REGULATION\",\"SUBUNIT\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/references/3",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q47720.json)

```json
{
  "evidence_id": "C7",
  "excerpt": "{\"citation\":{\"authors\":[\"Healy V.L.\",\"Park I.S.\",\"Walsh C.T.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"9545431\"},{\"database\":\"DOI\",\"id\":\"10.1016/s1074-5521(98)90633-0\"}],\"citationType\":\"journal article\",\"firstPage\":\"197\",\"id\":\"9545431\",\"journal\":\"Chem. Biol.\",\"lastPage\":\"207\",\"publicationDate\":\"1998\",\"title\":\"Active-site mutants of the VanC2 D-alanyl-D-serine ligase, characteristic of one vancomycin-resistant bacterial phenotype, revert towards wild-type D-alanyl-D-alanine ligases.\",\"volume\":\"5\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":5,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"MUTAGENESIS OF PHE-250 AND ARG-322\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/references/4",
  "retrieved_utc": "2026-11-02T04:30:46.048238+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "06db9d8bdf71a60d46c0d76bf8119766f2c979bd548827237a9036af1752f4cd",
  "url": "https://rest.uniprot.org/uniprotkb/Q47720.json"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147)

```json
{
  "entry_version": 147,
  "evidence_id": "H1",
  "excerpt": "ID   VANC2_ENTCA             Reviewed;         350 AA.\nAC   Q47720;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   01-NOV-1996, sequence version 1.\nDT   28-JAN-2026, entry version 147.\nDE   RecName: Full=Vancomycin C-type resistance protein VanC2 {ECO:0000303|PubMed:9294159, ECO:0000305};\nDE            EC=6.3.2.35 {ECO:0000269|PubMed:9294159, ECO:0000269|PubMed:9545431};\nDE   AltName: Full=D-alanine--D-serine ligase {ECO:0000255|HAMAP-Rule:MF_00047};\nDE   AltName: Full=VanC2 ligase {ECO:0000305};\nGN   Name=vanC2 {ECO:0000303|PubMed:9294159, ECO:0000303|PubMed:9545431,\nGN   ECO:0000312|EMBL:ABX79432.1};\nGN   Synonyms=ddl {ECO:0000255|HAMAP-Rule:MF_00047},\nGN   vanC-2 {ECO:0000312|EMBL:AAA60990.1};\nGN   ORFNames=P7I34_04740 {ECO:0000312|EMBL:MDT2981959.1};\nOS   Enterococcus casseliflavus (Enterococcus flavescens).\nOC   Bacteria; Bacillati; Bacillota; Bacilli; Lactobacillales; Enterococcaceae;\nOC   Enterococcus.\nOX   NCBI_TaxID=37734 {ECO:0000312|EMBL:AAA60990.1};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:30:51.643943+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 1-18",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "7cd95341b40880e3967efdffddc7f3a25c7982d99fb2b3f1cf21db004390d78a",
  "url": "https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147)

```json
{
  "entry_version": 147,
  "evidence_id": "H2",
  "excerpt": "RN   [4] {ECO:0000305}\nRP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY\nRP   REGULATION, AND SUBUNIT.\nRC   STRAIN=ATCC 25788 {ECO:0000303|PubMed:9294159};\nRX   PubMed=9294159; DOI=10.1073/pnas.94.19.10040;\nRA   Park I.S., Lin C.H., Walsh C.T.;\nRT   \"Bacterial resistance to vancomycin: overproduction, purification, and\nRT   characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser\nRT   ligase.\";\nRL   Proc. Natl. Acad. Sci. U.S.A. 94:10040-10044(1997).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:30:51.643943+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 42-51",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "7cd95341b40880e3967efdffddc7f3a25c7982d99fb2b3f1cf21db004390d78a",
  "url": "https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147)

```json
{
  "entry_version": 147,
  "evidence_id": "H3",
  "excerpt": "RN   [5] {ECO:0000305}\nRP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND\nRP   MUTAGENESIS OF PHE-250 AND ARG-322.\nRX   PubMed=9545431; DOI=10.1016/s1074-5521(98)90633-0;\nRA   Healy V.L., Park I.S., Walsh C.T.;\nRT   \"Active-site mutants of the VanC2 D-alanyl-D-serine ligase, characteristic\nRT   of one vancomycin-resistant bacterial phenotype, revert towards wild-type\nRT   D-alanyl-D-alanine ligases.\";\nRL   Chem. Biol. 5:197-207(1998).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:30:51.643943+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 52-60",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "7cd95341b40880e3967efdffddc7f3a25c7982d99fb2b3f1cf21db004390d78a",
  "url": "https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147)

```json
{
  "entry_version": 147,
  "evidence_id": "H4",
  "excerpt": "CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.\nCC       {ECO:0000255|HAMAP-Rule:MF_00047}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:30:51.643943+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 108-109",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "7cd95341b40880e3967efdffddc7f3a25c7982d99fb2b3f1cf21db004390d78a",
  "url": "https://rest.uniprot.org/unisave/Q47720?format=txt&versions=147"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 153. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
